Riskpilot← Back to searchSign inGet full access10x Genomics Sweden AB
ABActiveOrg 5569030579StockholmResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20125-9 employees
Revenue 2024
SEK 151,4M
-43% vs 2023
EBITDA margin
43.1%
-60% vs 2023
Equity ratio
76.3%
Financial strength
Net profit 2024
SEK 50,8M
-58% vs 2023
| Revenue | SEK 151,4M | -43% |
| EBITDA | SEK 65,2M | -60% |
| Net profit | SEK 50,8M | -58% |
| Total assets | SEK 106,4M | -71% |
| Equity | SEK 81,2M | -76% |
| Employees | — | — |
Legal name
10x Genomics Sweden AB
Org number
5569030579
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
6 september 2012
Share capital
SEK 50 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, bedriva verksamhet relaterad till biomedicin, förvaltning av lös och fast egendom, och därmed förenlig verksamhet.
Address
Stockholm
Email
ehsan.banisaid@10xgenomics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 77 608 | 159 178 | 256 284 | 267 546 | 151 371 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 28 643 | 78 185 | 145 361 | 163 387 | 65 242 |
| Depreciation & amort. | −4 053 | −7 439 | −10 172 | −9 754 | −3 566 |
| EBIT | 24 590 | 70 746 | 135 189 | 153 633 | 61 676 |
| Net financials | 835 | 4 641 | 641 | 14 | 2 423 |
| Profit before tax | 21 236 | 75 387 | 135 830 | 153 832 | 64 098 |
| Tax | −4 555 | −15 190 | −28 097 | −31 681 | −13 267 |
| Net profit | 16 681 | 60 197 | 107 733 | 122 151 | 50 831 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 65 389 | 135 638 | 260 403 | 370 232 | 106 385 |
| Equity | 36 267 | 96 464 | 204 197 | 334 985 | 81 209 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 29 123 | 39 174 | 56 206 | 35 246 | 25 176 |
| Total debt | 29 123 | 39 174 | 56 206 | 35 246 | 25 176 |
EBITDA margin
43.1%
This company
15.8%
Market median
+173% vs market
20202024
Equity ratio
76.3%
This company
38.2%
Market median
+100% vs market
20202024
Return on equity
62.6%
This company
18.4%
Market median
+240% vs market
20202024
Net profit margin
33.6%
This company
8.1%
Market median
+315% vs market
20202024
Asset turnover
1.42×
This company
1.12×
Market median
+27% vs market
20202024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JS Chief Executive Officer | Chief Executive Officer | 2025 |
NP Authorized Recipient of Service | Authorized Recipient of Service | 2024 |
IZ Chief Auditor | Chief Auditor | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
| Former (7) | ||
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2021 – 2024 | |
| Chairman | 2021 – 2024 | |
| Chairman | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
10X Genomics, Inc
10x Genomics Sweden AB Board members of 10x Genomics Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| James Sears Bryant | Chief Executive Officer | 0 companies |
| Nils Per Olof Hedman | Authorized Recipient of Service | 0 companies |
| Iuliia Zhuravel | Chief Auditor | 0 companies |
| Caroline Julie Gallant | Board of Directors | 0 companies |
| Per Morgan Sandström | Board of Directors | 0 companies |
| Jonas Kristoffer Frisén | Board of Directors | 0 companies |
| Michael Stubbington | Board of Directors | 0 companies |
| Ehsan Banisaid | Board of Directors | 0 companies |
| Eric Stewart Whitaker | Chairman | 0 companies |
| Elmar Ahmadov | Deputy Board Member | 0 companies |
| Eric Whitaker | Chairman | 0 companies |